About this trial
The current study aims to compare the performance of three distinct single-use digital flexible ureteroscope types in terms of cost-effectiveness, postoperative complications, operating time, and stone-free rates (SFRs).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 to 60 years.
Presence of renal stones measuring less than 20 millimeters (mm).
Disqualifiers
Renal stones larger than 20 millimeters (mm).
Uncontrolled bleeding disorders or coagulopathies.
Active urinary tract infection.
Renal failure.
Trial design
Parallel
Treatments tested in this trial
LithoVue™ (Boston Scientific Corporation)
DeviceParticipants randomized to this arm will undergo retrograde intrarenal surgery (RIRS) for renal stone management using the LithoVue™ single-use digital flexible ureteroscope.
WiScope® (OTU Medical Inc. (Silicon Valley, USA))
DeviceParticipants randomized to this arm will undergo retrograde intrarenal surgery (RIRS) for renal stone management using the WiScope single-use digital flexible ureteroscope.
Single-Use Ureterorenoscope (Scivita Medical Technology Co., Ltd.)
DeviceParticipants randomized to this arm will undergo retrograde intrarenal surgery (RIRS) for renal stone management using the single-use digital flexible ureterorenoscope manufactured by Scivita Medical Technology Co., Ltd.
Treatment groups
Trial outcomes
Primary outcomes
Cost-effectiveness of single-use flexible ureteroscopes
Comparison of total procedural cost and stone-free rate among three single-use flexible ureteroscopes used in retrograde intrarenal surgery (RIRS).
Secondary outcomes
Operative Time and Postoperative Complications
Incidence of postoperative complications within the postoperative period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.